24/7 Market News Snapshot 13 January, 2025 – NRX Pharmaceuticals, Inc. Common Stock (NASDAQ:NRXP)

January 13, 2025

DENVER, Colo., 13 January, 2025 (247marketnews.com) – (NASDAQ:NRXP) are discussed in this article.
NRX Pharmaceuticals, Inc. (NASDAQ:NRXP), a clinical-stage biopharmaceutical company specializing in innovative therapeutics for central nervous system disorders, has experienced a noteworthy surge in its stock price. Today, shares opened at $4.93 and have risen to $5.57, reflecting a substantial 14.89% increase from the previous session’s close of $4.85. This jump is accompanied by a trading volume of 1.62 million shares, signaling elevated investor interest and market activity.

The impressive stock performance coincides with the company’s announcement of its application to uplist to the NASDAQ Global Market, a strategic decision aimed at enhancing shareholder value and improving market liquidity. To qualify for this uplisting, NRx must meet NASDAQ’s criteria, which include a minimum market value of listed securities exceeding $75 million and maintaining a bid price of at least $4.00 for 90 consecutive trading days. With 15.7 million outstanding shares, NRx’s market capitalization will be a critical factor during this process.

Dr. Jonathan Javitt, Founder, Chairman, and CEO of NRx, highlighted the importance of this move, stating that it is expected to foster greater liquidity for shareholders while aligning with the criteria institutional investors require. NRx is committed to addressing critical health challenges, particularly in the realm of suicidal depression and PTSD, through its groundbreaking treatments, notably NRX-101 and the New Drug Application for NRX-100.

As the company progresses with its initiatives and uplisting plans, it remains focused on transparency, acknowledging the inherent risks of the biopharmaceutical industry. Stakeholders are encouraged to stay updated on NRx’s developments and its endeavors in the evolving market landscape, which may provide substantial growth opportunities moving forward.

Related news for (NRXP)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.